Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.14 CNY
117.05 M CNY
3.73 B CNY
454.36 M
About TIANJIN TIANYAO PHARMACEUTICAL
Sector
CEO
Shu Xiang Li
Headquarters
Tianjin
Website
Founded
1999
ISIN
CNE000001840
FIGI
BBG000JC8DP8
Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research, development, production and operation of APIs include corticosteroid, cardiovascular, and analgesic. Its products include veterinary drug, cosmetics, food additive , traditional chinese medicine extracts, raw materials and daily chemical products. The company was founded on December 1, 1999 and is headquartered in Tianjin, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 600488 is 4.44 CNY — it has increased by 0.67% in the past 24 hours. Watch TIANJIN TIANYAO PHARMACEUTICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange TIANJIN TIANYAO PHARMACEUTICAL stocks are traded under the ticker 600488.
600488 stock has risen by 1.13% compared to the previous week, the month change is a 9.27% rise, over the last year TIANJIN TIANYAO PHARMACEUTICAL has showed a −15.59% decrease.
600488 reached its all-time high on Jun 18, 2015 with the price of 13.29 CNY, and its all-time low was 1.46 CNY and was reached on Dec 5, 2005. View more price dynamics on 600488 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
600488 stock is 3.84% volatile and has beta coefficient of 0.97. Track TIANJIN TIANYAO PHARMACEUTICAL stock price on the chart and check out the list of the most volatile stocks — is TIANJIN TIANYAO PHARMACEUTICAL there?
Today TIANJIN TIANYAO PHARMACEUTICAL has the market capitalization of 4.87 B, it has increased by 3.01% over the last week.
Yes, you can track TIANJIN TIANYAO PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
TIANJIN TIANYAO PHARMACEUTICAL is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
600488 net income for the last quarter is 44.68 M CNY, while the quarter before that showed 84.01 M CNY of net income which accounts for −46.82% change. Track more TIANJIN TIANYAO PHARMACEUTICAL financial stats to get the full picture.
Yes, 600488 dividends are paid annually. The last dividend per share was 0.09 CNY. As of today, Dividend Yield (TTM)% is 1.96%. Tracking TIANJIN TIANYAO PHARMACEUTICAL dividends might help you take more informed decisions.
TIANJIN TIANYAO PHARMACEUTICAL dividend yield was 1.78% in 2023, and payout ratio reached 81.16%. The year before the numbers were 0.23% and 30.86% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 22, 2024, the company has 2.68 K employees. See our rating of the largest employees — is TIANJIN TIANYAO PHARMACEUTICAL on this list?
Like other stocks, 600488 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TIANJIN TIANYAO PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TIANJIN TIANYAO PHARMACEUTICAL technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TIANJIN TIANYAO PHARMACEUTICAL stock shows the sell signal. See more of TIANJIN TIANYAO PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.